Potent Antibacterial Peptides Engineered from a Fish Venom Peptide

Pardaxin — a pore-forming peptide from Moses sole fish — has strong antibacterial activity, and engineered derivatives show even greater potency with reduced toxicity to mammalian cells.

Oren, Z et al.·European journal of biochemistry·1996·Moderate Evidencein-vitro
RPEP-00376In VitroModerate Evidence1996RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
in-vitro
Evidence
Moderate Evidence
Sample
Not reported

What This Study Found

Pardaxin possesses high antibacterial activity, and engineered variants achieved potent bacterial killing while reducing harmful effects on mammalian cells.

Key Numbers

How They Did This

In vitro testing of pardaxin and engineered derivatives for antibacterial activity against various strains and cytotoxicity against mammalian cells.

Why This Research Matters

Engineering selective antibacterial peptides from natural toxins provides a template for developing new antibiotics that kill bacteria without harming human cells — critical as antibiotic resistance grows.

The Bigger Picture

This study exemplifies how nature's arsenal of toxic peptides can be rationally modified for medical use, a strategy that continues to drive antimicrobial peptide drug development.

What This Study Doesn't Tell Us

In vitro study only. Engineered peptides need in vivo testing for stability, bioavailability, and safety before clinical development.

Questions This Raises

  • ?Can pardaxin derivatives be made stable enough for systemic use as antibiotics?
  • ?What other venom peptides could serve as templates for antimicrobial drug design?

Trust & Context

Key Stat:
Selective bacterial killing achieved Engineered pardaxin derivatives maintained antibacterial potency while reducing mammalian cell toxicity
Evidence Grade:
Moderate in vitro evidence demonstrating proof-of-concept for engineering selective antimicrobials from natural toxins.
Study Age:
Published in 1996, this study represents early work in rational antimicrobial peptide engineering that has since become a major research area.
Original Title:
A class of highly potent antibacterial peptides derived from pardaxin, a pore-forming peptide isolated from Moses sole fish Pardachirus marmoratus.
Published In:
European journal of biochemistry, 237(1), 303-10 (1996)
Authors:
Oren, Z, Shai, Y
Database ID:
RPEP-00376

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / ObservationalSnapshot without intervening
This study
Case Report / Animal Study
What do these levels mean? →

Frequently Asked Questions

What is pardaxin?

Pardaxin is a 33-amino-acid peptide toxin secreted by the Red Sea Moses sole fish as a defense mechanism. It kills cells by forming pores in their membranes, similar to how some natural antibiotics work.

How do you make a toxin into an antibiotic?

By modifying the peptide's structure to maintain its membrane-disrupting activity against bacteria while reducing its ability to damage human cells. This selectivity engineering exploits differences between bacterial and mammalian cell membranes.

Read More on RethinkPeptides

Cite This Study

RPEP-00376·https://rethinkpeptides.com/research/RPEP-00376

APA

Oren, Z; Shai, Y. (1996). A class of highly potent antibacterial peptides derived from pardaxin, a pore-forming peptide isolated from Moses sole fish Pardachirus marmoratus.. European journal of biochemistry, 237(1), 303-10.

MLA

Oren, Z, et al. "A class of highly potent antibacterial peptides derived from pardaxin, a pore-forming peptide isolated from Moses sole fish Pardachirus marmoratus.." European journal of biochemistry, 1996.

RethinkPeptides

RethinkPeptides Research Database. "A class of highly potent antibacterial peptides derived from..." RPEP-00376. Retrieved from https://rethinkpeptides.com/research/oren-1996-a-class-of-highly

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.